Published in J Pharm Sci on November 01, 1986
Nasal drug delivery devices: characteristics and performance in a clinical perspective-a review. Drug Deliv Transl Res (2012) 1.18
Nanotechnology for CNS delivery of bio-therapeutic agents. Drug Deliv Transl Res (2013) 0.86
Development and Validation of a Reversed-Phase High-performance Liquid Chromatography Method for Determination of Desmopressin in Chitosan Nanoparticles. Indian J Pharm Sci (2013) 0.75
Molecular pathology of haemophilia B. EMBO J (1989) 2.74
Computers and the effectiveness of the measles vaccination campaign in England and Wales. Community Med (1979) 2.13
Thromboembolic disease--critical evaluation of laboratory investigation. Thromb Haemost (1992) 1.93
Fibrinolytic activity of human veins. Lancet (1967) 1.91
AHF related protein in clinical praxis. Scand J Haematol (1974) 1.78
Defective fibrinolysis in blood and vein walls in recurrent "idiopathic" venous thrombosis. Acta Chir Scand (1972) 1.74
The incidence and distribution of CpG----TpG transitions in the coagulation factor IX gene. A fresh look at CpG mutational hotspots. Nucleic Acids Res (1990) 1.64
Clinical pharmacology of aminocaproic and tranexamic acids. J Clin Pathol Suppl (R Coll Pathol) (1980) 1.64
Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis. Nat Med (1999) 1.61
A radiologic classification of hemophilic arthropathy. Clin Orthop Relat Res (1980) 1.59
Hepatitis C virus transmission by monoclonal antibody purified factor VIII concentrate. Lancet (1990) 1.53
Plasma exudation as a first line respiratory mucosal defence. Clin Exp Allergy (1991) 1.52
Intrauterine death and circulating anticoagulant ("antithromboplastin"). Acta Med Scand (1975) 1.51
A nascent secretory protein may traverse the ribosome/endoplasmic reticulum translocase complex as an extended chain. J Biol Chem (1996) 1.51
Determination of plasminogen in clots and thrombi. Thromb Diath Haemorrh (1966) 1.48
Coagulation and fibrinolytic studies during pregnancy. Acta Obstet Gynecol Scand (1967) 1.48
Mechanism of plasminogen activator and factor VIII increase after vasoactive drugs. Br J Haematol (1975) 1.47
Haemophilia prophylaxis in Sweden. Acta Paediatr Scand (1976) 1.46
Haemophilia prophylaxis in young patients--a long-term follow-up. J Intern Med (1997) 1.44
Intravascular coagulation and acute renal failure in a child with mycoplasma infection. Acta Med Scand (1971) 1.44
Topical vasoconstrictor (oxymetazoline) does not affect histamine-induced mucosal exudation of plasma in human nasal airways. Clin Exp Allergy (1992) 1.42
[Threatened future of plasma products. Who is responsible?]. Lakartidningen (1996) 1.39
Potassium and experimental coronary occlusion. Am Heart J (1966) 1.37
Mechanisms of cytoskeletal regulation. Modulation of aortic endothelial cell spectrin by the extracellular matrix. Am J Pathol (1984) 1.33
The dual role of interferon-gamma in experimental Staphylococcus aureus septicaemia versus arthritis. Immunology (1998) 1.30
Experimental and clinical studies on AMCA, the antifibrinolytically active isomer of p-aminomethyl cyclohexane carboxylic acid. Scand J Haematol (1965) 1.29
Two genetic variants of von Willebrand's disease. N Engl J Med (1973) 1.25
Aberrant multimeric structure of von Willebrand factor in a new variant of von Willebrand's disease (type IIC). J Clin Invest (1982) 1.23
[Risk of thromboembolism with oral contraceptives]. Lakartidningen (1967) 1.23
The use of the nose to study the inflammatory response of the respiratory tract. Thorax (1992) 1.22
Mechanisms of cytoskeletal regulation: functional and antigenic diversity in human erythrocyte and brain beta spectrin. J Cell Biochem (1986) 1.21
Evaluation and correction of dysphagia-producing cervical osteophytosis. Laryngoscope (1974) 1.20
Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor. Br Med J (Clin Res Ed) (1985) 1.19
Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease. N Engl J Med (1983) 1.18
The 'nasal pool' device applies controlled concentrations of solutes on human nasal airway mucosa and samples its surface exudations/secretions. Clin Exp Allergy (1990) 1.15
Coagulation and fibrinolytic studies during use of gestagens. Acta Obstet Gynecol Scand (1967) 1.14
Albumin, bradykinins, and eosinophil cationic protein on the nasal mucosal surface in patients with hay fever during natural allergen exposure. J Allergy Clin Immunol (1990) 1.14
Catheter material and blood coagulation studies in vitro. Scand J Haematol (1969) 1.13
Mechanism of cytoskeletal regulation (I): functional differences correlate with antigenic dissimilarity in human brain and erythrocyte spectrin. Biochim Biophys Acta (1985) 1.13
Fibrinolysis in newborns. Acta Paediatr Scand (1970) 1.12
New aspects of the pathogenesis of thrombo-embolism. Prog Surg (1973) 1.11
Fibrin degradation products and ovarian tumours. Br Med J (1971) 1.08
Thrombolytic effect of streptokinase as evaluated by phlebography of deep venous thrombi of the leg. Acta Chir Scand (1970) 1.08
Thrombosis and oral contraceptives: possible predisposition. Br Med J (1973) 1.07
Beta spectrin bestows protein 4.1 sensitivity on spectrin-actin interactions. J Cell Biol (1987) 1.07
Coagulation and fibrinolytic studies during continuous use of low dose gestagen. Acta Endocrinol (Copenh) (1970) 1.07
Immunosuppressive treatment in haemophiliacs with inhibitors to factor VIII and factor IX. Scand J Haematol (1976) 1.06
Shelf-life of bank blood and stored plasma with special reference to coagulation factors. Transfusion (1983) 1.06
"Fibrinolytic capacity" in healthy volunteers as estimated from effect of venous occlusion of arms. Acta Chir Scand (1972) 1.05
Binding of delta-1-tetrahydrocannabinol to human plasma proteins. Biochem Pharmacol (1970) 1.05
Value of streptokinase and heparin in treatment of acute deep venous thrombosis. A coded investigation. Acta Chir Scand (1968) 1.04
Genetic variants of von Willebrand's disease. Br Med J (1972) 1.03
Reversibility and reproducibility of histamine induced plasma leakage in nasal airways. Thorax (1989) 1.03
Our experience in Sweden with prophylaxis on haemophilia. Bibl Haematol (1970) 1.03
Inhibition of platelet prothrombinase activity by a lupus anticoagulant. Blood (1983) 1.02
Fibrinolysis and subarachnoid haemorrhage. Inhibitory effect of tranexamic acid. A clinical study. Acta Neurol Scand (1972) 1.02
Coagulation and fibrinolysis in chronic panniculitis. Acta Derm Venereol (1970) 1.02
Thrombosis in the superior mesenteric and portal veins: report of a case treated with thrombectomy. Surgery (1974) 1.02
Factor XIII (fibrin stabilising factor) in Henoch-Schönlein's purpura. Acta Paediatr Scand (1977) 1.02
An HphI-polymorphism in exon 28 of the von Willebrand factor gene, and its frequency among patients with various forms of von Willebrand's disease. Br J Haematol (1991) 1.02
Factor VIII antigen in the vessel walls in von Willebrand's disease and haemophilia A. Scand J Haematol (1974) 1.02
The role of beta-1-adrenoceptors in the renin release response to graded renal sympathetic nerve stimulation. Pflugers Arch (1980) 1.01
Pregnancy and parturition in a patient with severe Glanzmann's thrombasthenia. Scand J Haematol (1981) 1.01
Serum fibrin-fibrinogen degradation products in acute myocardial infarction. Lancet (1972) 1.00
Diagnostic symptoms of severe and moderate haemophilia A and B. A survey of 140 cases. Acta Paediatr Scand (1990) 1.00
Airway permeability. Clin Exp Allergy (1995) 0.99
Fibrinolytic activity of human veins in arms and legs. Thromb Diath Haemorrh (1968) 0.99
"Fibrinolytic capacity" in healthy volunteers at different ages as studied by standardized venous occlusion of arms and legs. Acta Med Scand (1972) 0.99
Effect of treatment with combined phenformin and ethyloestrenol on the coagulation and fibrinolytic systems. Scand J Haematol (1970) 0.99
Autologous blood transfusion in revision hip arthroplasty. A prospective, controlled study of 30 patients. Acta Orthop Scand (1992) 0.98
Two factor IX mutations in the family of an isolated haemophilia B patient: direct carrier diagnosis by amplification mismatch detection (AMD). Hum Genet (1990) 0.98
Haemophilia B mutations in a complete Swedish population sample: a test of new strategy for the genetic counselling of diseases with high mutational heterogeneity. Br J Haematol (1991) 0.98
Comparison of intranasal and oral desmopressin for nocturnal enuresis. Arch Dis Child (1987) 0.97
Coagulation studies in different types of myeloma. Acta Med Scand Suppl (1966) 0.97
Diabetic retinopathy and the fibrinolytic system. Diabetes (1975) 0.97
Recurrent thrombosis in a young woman with a circulating anticoagulant directed against factors XI and XII. Acta Med Scand (1972) 0.96
Occurrence of arteriosclerosis in von Willebrand's disease. Acta Med Scand (1966) 0.96
Origin of mutation in sporadic cases of haemophilia-B. Eur J Haematol (1992) 0.96
von Willebrand's disease. Eur J Haematol (1992) 0.96
Fibrinolytic activity of the cerebrospinal fluid after subarachnoid haemorrhage. Acta Neurol Scand (1973) 0.95
Effects of concentration and volume on nasal bioavailability and biological response to desmopressin. J Pharm Sci (1988) 0.95
Cancer, F.D.P., and radiotherapy. Br Med J (1972) 0.94
Induction of split tolerance and clinical cure in high-responding hemophiliacs with factor IX antibodies. Proc Natl Acad Sci U S A (1986) 0.94
Urokinase inhibitors in serum in a clinical series. Acta Med Scand (1971) 0.93
Coagulation, fibrinolysis and venous thrombosis. Triangle (1977) 0.93
Elimination of tritium-labelled cannabinols in the rat with special reference to the development of tests for the identification of cannabis users. Biochem Pharmacol (1969) 0.93
Gastric fibrinolysis. Thromb Diath Haemorrh (1975) 0.93
Smoking and fibrinolysis. Circulation (1975) 0.92
Technical remarks on the microscopical demonstration of tissue plasminogen activator. Thromb Diath Haemorrh (1972) 0.92
Immunological characterisation of plasminogen activators in the human vessel wall. J Clin Pathol (1983) 0.92
Effect of viscosity on particle size, deposition, and clearance of nasal delivery systems containing desmopressin. J Pharm Sci (1988) 0.92
Phenformin and ethyloestrenol in recurrent venous thrombosis. Acta Med Scand (1975) 0.91
Hypofibrinogenaemia and massive thrombosis. Acta Med Scand (1966) 0.91
[Blood loss in Charnley's total hip replacement]. Lakartidningen (1977) 0.91
von Willebrand's disease characterized by increased ristocetin sensitivity and the presence of all von Willebrand factor multimers in plasma. Blood (1986) 0.90
Studies on blood clotting factors in man after massive liver resection. Acta Chir Scand (1967) 0.90
Immunologic studies in haemophilia A. Scand J Haematol (1973) 0.90